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ABSTRAK 
Pengenalan masalah :  Permasalahan salur darah  sempit dan beku sering berlaku  pada 
saluran darah fistula para pesakit hemodialisis. Rawatan awal melalui prosedur bukaan salur 
darah sempit (PTA) dapat membantu, tetapi timbul persoalan sejauh  mana  prosedur  ini 
dapat  meningkatkan fungsi hemodialisis. Setakat ini belum banyak kajian yang 
merungkaikan persoalan  ini dan dengan  itu kami menjalankan kajian  yang bertajuk 
“Korelasi diantara  salur darah sempit fistula dan parameter hemodialisis, sebelum dan 
selepas prosedur bukaan salur darah”. 
Objektif:  Menentukan kaitan antara peratusan salur darah sempit fistula dengan fungsi 
hemodialisis.  
Metodologi:  Seramai 47 pesakit menjalani prosedur bukaan salur darah sempit fistula (PTA) 
di unit AMIEN HUSM dari bulan Jun 2014 sehingga Oktober 2015; 14 subjek ditolak kerana 
tidak memenuhi kriteria kajian, dan 19 hilang data menjadikan jumlah sampel sebanyak 14 
sahaja. Diameter salur darah sempit fistula sebelum dan selepas prosedur bukaan salur darah 
sempit (PTA) diukur melalui sistem PACS, manakala informasi berkenaan parameter 
hemodialisis dikumpul dengan membuat panggilan telefon ke pusat hemodialisis subjek. 
Keputusan: Kajian ini menunjukkan korelasi yang lemah diantara peratusan salur darah 
sempit dengan kadar pam darah (Qb). Tiada  korelasi diantara peratusan salur darah sempit 
dengan  tekanan vena hemodialisis (Vp). Teknikal sukses sebanyak 57.1% (P=0.001). 
Kesimpulan: Kajian ini mendapati  korelasi yang lemah diantara peratusan bukaan salur 
darah sempit dengan kadar pam darah dialisis (Qb) tetapi tidak pada tekanan vena 
hemodialisis (Vp).  
xii 
 
ABSTRACT 
Introduction: Stenosis and thrombosis of Arterio-Venous Fistula (AVF) has been an ongoing 
problem in hemodialysis patients. Early treatment by Percutaneous Transluminal Angioplasty 
(PTA) helps in maintaining AVF patency. However, how much PTA would improve the 
hemodialysis function was still questionable and only few literatures discussed on this matter. 
Hence, we performed a study on “Correlation of Vascular Stenosis with Hemodialysis 
Parameters in Native Arteriovenous Fistula (AVF), Pre and Post Percutaneous Transluminal 
Angioplasty”. 
Objective: To determine association between percentage of residual stenosis with 
hemodialysis success. 
Methodology:  A total of 47 patients underwent Percutaneous Transluminal Angioplasty 
(PTA) in AMIEN Unit HUSM from June 2014 till October 2015; 14 were excluded and 19 
lost to follow up leaving 14 subjects to study. All measurements of stenosis diameter were 
made from the PACS system whereas hemodialysis parameters were gathered through phone 
call to the subjects’ regular hemodialysis centre. 
Results: This study has revealed a weak correlation between percentage of stenosis with 
blood pump flow rate (Qb) in pre and post PTA. No correlation between percentage of 
stenosis with venous dialysis pressure (Vp) in pre and post PTA.  The achieved technical 
success was 57.1% (P = 0.001). 
Conclusion: There is weak correlation between degree of stenosis with blood pump flow rate 
(Qb) but not observed in venous dialysis pressure (Vp). 
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Chapter 1 
Introduction 
  
 End stage renal failure is a debilitating and life long illness. There are multifactorial 
factors which lead to this illness and the most commonly found reason is diabetes. The affected 
population is primarily older people but there is a prevailing trend involving patients of younger 
age. In Malaysia, the number of population diagnosed with ESRF has increased. In 2008, data 
from the National Renal Registry Malaysia reported an increase of dialysis acceptance rate to 
116 per million population compared to 3 per million population recorded in 1980 (Lim et al., 
2008). 
 The treatment for ESRD is a renal replacement therapy (RRT) which includes 
haemodialysis, peritoneal dialysis (CAPD) and renal transplant. Haemodialysis is most 
commonly practiced among large population due to its availability and accessibility. 
Haemodialysis requires vascular access. The most favourable vascular access is surgically 
created arteriovenous fistula (AVF) as it provides good patency with low complication rate 
(Tordoir et al., 2007) (NKF, 2006). Despite that, AVF still pose risks of developing stenosis and 
thrombosis; if undetected and untreated may cause AVF dysfunction. Hence, the importance of 
monitoring and detecting earlier signs of AVF stenosis.  
 There are two methods of detecting AVF dysfunction which include monitoring and 
surveillance. It is found that monitoring by means of physical examination is less advantageous 
compared to surveillance method as the former detects stenosis or thrombosis later.  
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 Percutaneous transluminal angioplasty (PTA) is a minimally invasive procedure in which 
it restores the stenosed or thrombosed AVF. So far, this has become the most suggested first line 
procedure prior to resort to surgical revision. Beathard (1992) argues for PTA as a first line 
treatment for AVF dysfunction in view of shorter procedure, minimal stress to the patient, no 
requirement for hospitalization and this procedure enables immediate dialysis without the need 
for a central venous catheter. This procedure also reduces the chances of infection and preserves 
the rest of upper extremity veins  
 Reviewed literatures on post PTA successfulness primarily provides accounts on 
technical and hemodynamic success. Nevertheless, the term technical success was 
interchangeably used with anatomical success, whereas hemodynamic success was 
interchangeably used with clinical success. To avoid confusion, our study uses the term technical 
and hemodynamic success. 
 Numerous work in the past have reported significant successful rate of PTA in terms of 
technical success (Long et al., 2011; Tang et al. (1998); Tessitore et al., 2003) and 
hemodynamic success (Ahya et al., 2001; Long et al., 2011; Tang et al., 1998). A prospective 
study with 62 subjects by Tessitore et al. (2003) showed a technical success rate of 93.3%. 
Similar results were also observed in few retrospective studies with a technical success of more 
than 90% (Aktas et al., 2015; Long et al., 2011) , clinical success of 97.2% (Aktas et al., 2015), 
75% (Long et al., 2011) and both technical and clinical success of 73% (Tang et al., 1998). 
 Nonetheless, not much studies have been done to observe in particular the correlation 
between percentage of stenosis and the hemodynamic improvement it caused in pre and post 
PTA of the intervened dysfunctional AVF. Ahya et al. (2001) found no correlation between 
changes in percentage stenosis and the improvement of blood flow post PTA, however it showed 
a significant correlation (p value 0.001) between pre and post PTA blood access flow regardless 
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of the percentage of stenosis changes. In contrary to a study by Beathard (1992) there was a 
significant correlation between changes in percentage stenosis with venous dialysis pressure (p 
value <0.001). 
 In this study, we are looking at both venous pressure (Vp) and blood pump flow rate 
(Qb) as the parameters for hemodynamic success. Thus, the objective of this study is to 
determine association between percentages of stenosis with hemodialysis success in pre and post 
PTA.  
 The rationale of this study is to provide an overview on the importance of Vp and Qb 
parameters for hemodynamic success post PTA and surveillance for early detection of AVF 
dysfunction. In line with that, should there be any suspicion of stenosis, an early referral for 
fistulogram and further PTA might reduce the chances of failed or unsalvageable AVF. 
Moreover, dedicated surveillance will detect the early stage of stenosis, provides early 
intervention,  higher PTA success and eventually increases the AVF longevity. 
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Chapter 2 
Literature Review 
 
2.1 Introduction to End Stage Renal Failure (ESRD) 
 End Stage Renal Disease is the manifestation of chronic kidney disease. 
 
2.1.1 Chronic Kidney Disease 
 Chronic Kidney Disease refers to kidney damaged with the presence of albuminuria or a 
reduction in kidney function with glomerular filtration rate (GFR) of less than 60 mL/min per 
1.73m2 for 3 months duration or more. There are multistages of chronic kidney disease; stage1; 
GFR more than 90 mL/min per 1.73 m , stage 2; GFR 60–89 mL/min per 1.73 m , stage 3; GFR 
30–59 mL/min per 1.73 m , stage 4; GFR 15–29 mL/min per 1.73 m  and stage 5 (renal failure) 
is GFR of less than 15mL/min per 1.73 m  (Levey and Coresh, 2012). 
 
2.1.2 ESRD 
 Progression of chronic kidney disease to stage 5 known as ESRD with GFR less than 
15mL/min per 1.73m  left the renal function incompatible with life and requires treatment to 
replace renal function  (Haynes and Winearls, 2010) either by means of dialysis, or 
transplantation (Levey and Coresh, 2012).  
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 There are multifactorial causes which lead to the development of ESRD such as diabetes 
mellitus, hypertension, lupus nephritis, glomerulonephritis and renal stone. Hypertension and 
diabetes mellitus in chronic kidney disease predispose to faster progression to ESRD 
("Association of Level of GFR with Complications in Adults Part 6.," 2002). It is found that 
diabetes accounts for higher prevalence of ESRD with 46.7% compared to hypertension which is 
reported at 28.4% (Wright et al., 2010). 
 In Malaysia, the number of population diagnosed with ESRD has increased. The data 
reported by the National Renal Registry Malaysia in 2008 points to the escalating number of 
dialysis acceptance rates from 3 per million population  in 1980 to 116 per million population in 
2008 (Lim et al., 2008). 
 
2.2 Dialysis 
 Dialysis is one form of renal replacement therapy which is widely available as compared 
to renal transplant. Dialysis removes uremic toxins, excess extracellular fluid and electrolytes 
(sodium and potassium) by equilibrating the patient’s blood to dialysate fluid with a semi-
permeable membrane in between (Haynes and Winearls, 2010).There are two types of dialysis 
namely haemodialysis and peritoneal dialysis; the former is preferable due to its easy access and 
less risk of infection. 
2.2.1 Haemodialysis 
 Haemodialysis involves an extracorporeal blood circuit and an artificial membrane to 
allow most small uremic toxin molecules across but small enough to ensure essential proteins are 
not removed. Dialysate fluid is passed in the opposite direction on the other side of the 
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membrane so a diffusive gradient is maintained leading to toxin removal into the dialysate. The 
trans-membrane pressure can be increased to force extra fluid across the membrane allowing the 
extracellular volume to be controlled and toxins to be removed by filtration.  
 There have been debates concerning suitable timing of starting haemodialysis treatment. 
Most patients (66.4%) commenced haemodialysis with an estimated GFR between 5.0 and 10 
mL/min/1.73 m2 (Wilson et al., 2007). It is found that patients who started dialysis at an eGFR 
of ≤5 ml/min per 1.73 m2 have reduced risk of mortality. An incremental increase in mortality 
risk however is observed in patients whose dialysis started at an eGFR >10 to 15 ml/min per 
1.73 m2 (Wilson et al., 2007). Patients’ prognosis is to be better with lower initial GFR 
(Yamagata et al., 2012). In contrast to a study conducted by Korevaar et al. (2001),  there is no 
significant differences in survival rate between late starters and timely starters.  
 
2.3 Vascular Access 
 The availability of vascular access in haemodialysis patient is very important as it 
ensures patient received adequate treatment as per scheduled (commonly three times a week). 
There are two types of vascular access for haemodialysis patient. These types of access include 
temporary vascular access (central venous catheterization of the internal jugular, subclavian or 
femoral veins) and permanent vascular access (arteriovenous fistula, arteriovenous graft). 
Among all, arteriovenous fistula (AVF) is the best form of haemodialysis access (Zaleski, 2004). 
The NKF (1997) DOQI guidelines recommend that AV fistulae should be the first option in 
view of early patency was found in 94.0% of the AVF created (Iyem, 2011). 
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2.3.1  Arteriovenous Fistula (AVF) 
 AVF creation was first introduced by Brescia and Cimino in 1966.  It is created 
surgically as a vascular access for hemodialysis treatment. Despite the introduction of AV grafts 
(PTFE graft), native AVF is still preferable due to its higher patency, low incidence of stenosis, 
thrombosis and infection.   
 There are three types of anastomosis techniques in AVF creation; namely (i) side to side 
anastomosis, (Sprouse Ii et al.) end to end anastomosis and (Sprouse Ii et al.) side to end 
anastomosis. The third technique is most commonly adopted as it avoids creation of acute angle 
and should thrombosis occurs, it only affects the venous limb (Konner et al., 2003) 
 Location of fistula are grouped into: (i) distal fistula, comprises of distal radiocephalic 
fistula (DRCF) and radiocephalic Fistula (RCF), (Sprouse Ii et al.) middle radio-cephalic fistula 
(MRCF) and (Sprouse Ii et al.) proximal fistula, includes Brachiocephalic Fistula (BCF) and 
Brachiobasilic Fistula (BBF)(Wan Najmi, 2012) 
 A minimum of 28 days after creation need to be allowed for AVF to mature before it is 
used for hemodialysis (Rajabi-Jaghargh and Banerjee, 2015).  
 
2.3.2  AVF Dysfunction 
 A dysfunctional AVF is defined as an access that is unable to provide the minimum flow 
(350-450 mL/min) during the 3 to 5 hour dialysis and it is clinically evident by changes in thrills 
pattern, difficult cannulation, recirculation, excessive bleeding from the venepuncture sites and 
thrombosis formation (Rajabi-Jaghargh and Banerjee, 2015).  
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2.3.3  AVF stenosis and thrombosis 
 Over time, AVF patency will be reduced due to stenosis and thrombosis formation. The 
pathophysiology behind this is the turbulence flow of blood created by the AVF itself which 
activates platelets and endothelial cells (Konner et al., 2003). In addition, multiple punctures 
over the AVF has resulted in iatrogenic remodelling of the vessel (Krönung, 1984) and formed a 
defect which later on replaced by thrombus (Konner et al., 2003). AVF thrombosis is also 
triggered by a critical reduction of fistula blood flow (Konner et al., 2003). 
 Basically, AVF stenosis can occur anywhere along the fistula; venous limb, ostium and 
arterial limb (Figure 4.3) and can be divided into inflow or outflow stenosis. An inflow stenosis 
is where the thrombosis formed around the anastomosis and proximal to the venous needle. An 
outflow stenosis is located further away from the anastomosis site and distal to the venous 
needle (Rajabi-Jaghargh and Banerjee, 2015). Inflow stenosis is prone to occur at the Radio-
cephalic AVF, whereas the outflow stenosis is more likely to occur at the Brachiocephalic AVF 
(Rajabi-Jaghargh and Banerjee, 2015). The creation of the upper arm fistulae shows greater 
tendency to develop thrombosis  (Turmel-Rodrigues et al., 2000) compared to forearm fistula 
(Zaleski, 2004).  
 
2.4  Detection of AVF dysfunction 
 Early recognition of AVF dysfunction is crucial by means of continuous monitoring and 
surveillance. This is to preserve the AVF from functional loss or unsalvageable.  
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2.4.1  Monitoring 
 Regular physical examination of the AVF can easily be performed by the patient or by 
the attending staff of hemodialysis unit. It could be observed that a well-functioning fistula will 
have a soft continuous thrill along its outflow segment, compressible, empties on arm elevation 
and low pitched continuous bruit on auscultation.  
 Absence of thrills, a strong water hammer pulse and failure to collapse on arm elevation 
are more suggestive of outflow stenosis. Meanwhile a weak pulse, loss of augmentation and high 
pitched bruit are more suggestive of inflow stenosis. Other signs of AVF dysfunction include 
persistent cannulation difficulties (Tessitore et al., 2014) and prolonged bleeding post 
cannulation (Sigala et al., 2014; Tessitore et al., 2014). 
 AVF dysfunction has a strong association with central vein stenosis. This can be 
suspected in the event of unilateral arm swelling and multiple collaterals over the chest.  
 
2.4.2  Surveillance  
 Fistula surveillance is divided into two; flow surveillance and pressure surveillance. 
 2.4.2.1 Flow surveillance 
 Flow surveillance include two parameters; blood pump flow rate (Qb) and access blood 
 flow (Qa). 
a) Blood pump flow rate (Qb)  
 Blood pump flow rate (Qb) is under documented as a surveillance parameter to detect 
dysfunctional fistula, whereas more research is found dedicated to access blood flow rate (Qa). 
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However a prospective study by Tessitore et al. (2003) have adopted the changes in Qb as part 
of their surveillance programme. In their study, subjects with decreased Qb for two consecutive 
hemodialysis sessions were included as candidates for PTA.  
b) Access blood flow rate (Qa) 
 There were much literature with positive reviews on the usefulness of Qa in detecting 
dysfunctional fistula at early stage. The Qa is measured using ultrasound where direct and 
indirect measurements were performed. Direct measurement used Doppler ultrasound, whereas 
indirect measurement used ultrasound dilution, transcutaneous flow rate, glucose infusion, 
differential conductivity and ionic dialysance.  
 A Qa < 500 ml/min by Tonelli 2001 shows 81% positive stenosis on angiogram (Tonelli 
et al., 2001). Polkinghorne, 2006 also gave similar result where seven patients with baseline of 
Qa <500 ml/min showed significant stenosis at angiogram. Meanwhile, a higher strength of Qa < 
900 mL/min were  found positive for stenosis in a study by Tessitore et al. (2014). 
 Qa measurement showed accuracy of 73% to 80% for inflow stenosis especially when 
combined with physical examination (Tessitore et al., 2011). Blood access flow less than 1000 
mL/min or 20% reduction, leads to prediction of a hemodynamically significant AVF stenosis 
(Schwab et al., 2001). Furthermore, there was a high positive predictive value of Qa to detect 
significant stenosis at 87% (Moist et al., 2003). 
 2.4.2.2 Pressure surveillance 
 Pressure Surveillance is the measurement of inherent pressure gradient between the 
artery and the vein across the arterial anastomosis. The change in intraaccess pressures (IAP) in 
an AVF depends on the site of stenosis and the presence or absence of collateral veins 
(Vachharajani, 2012). Direct pressure gradient measurement within the fistula provided more 
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information regarding stenosis than ultrasound (Zaleski, 2004).  According to Beathard, 1992 
the normal mean Vp was 77.4+-27.4mmHg using a 16 Gauge needle, and abnormal Vp was 
more than 100 mmHg  for  three  consecutive treatment (Beathard, 1992). Previous study with 
112 subjects showed a high positive predictive value of Vp in detecting AVF stenosis (Moist et 
al., 2003). Similarly, a progressive increased in venous dialysis pressure (Vp) on consecutive 
dialysis session was associated with AVF stenosis (Konner et al., 2003).  
 On the other hand, Polkinghorne, 2006 found that Vp was a poor screening test for AVF 
dysfunction in which only 3 of 15 patients with high Vp were positive on angiogram 
(Polkinghorne et al., 2006). Instead, an increased derived static pressure (Vp0) of more than 0.5 
with no drop in Qa level were associated with access loss or thrombosis (Tessitore et al., 2014). 
 Combination of physical examination and static venous pressure (Vp0) > 0.5 showed an 
excellent diagnostic performance for outflow stenosis with an accuracy >85% (Tessitore et al., 
2011). An increased in static venous pressure (Vp0) was associated with significant stenosis at 
venous limb and anastomotic site as compared to dynamic venous dialysis pressure (Vp)(Smits 
et al., 2001).  
 
2.5 Fistulogram 
 Suspicion of AVF dysfunction from monitoring and surveillance means will be 
confirmed by fistulogram. It is an imaging of the entire vascular access of AVF by injecting 
contrast preferably from the venous limb. From this study, the site and degree of stenosis can be 
evaluated. 
 A significant degree of stenosis has been widely defined in the literatures as a local 
reduction of luminal diameter of more than 50% as compared to the adjacent normal vessel 
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(Beathard, 1992; Long et al., 2011; Polkinghorne et al., 2006; Richard J. Gray, Amended 2014 ; 
Tessitore et al., 2003). 
 
2.6  Percutaneous Transluminal Angioplasty (PTA) 
 Once AVF stenosis or thrombosis developed, choices of treatment include percutaneous 
transluminal angioplasty (PTA) or surgical revision. PTA is preferable method to restore blood 
flow for thrombosed or malfunctioning native fistula (Zaleski, 2004) because it is less invasive, 
highly repeatable and more access length sparing. Moreover, with PTA there will be no surgical 
wound, able to resume hemodialysis immediately through the intervened AVF, avoid the need 
for central catheter placement and reduced hospitalization (Bountouris et al., 2014). Napoli et al, 
.2010, suggested that PTA should be is the first to be done as assisted primary patency, whereas 
surgical revision is preserved if PTA failed (Napoli et al., 2010). 
 Definition of successful PTA is varied among different published literatures with 
interchangeable use of terms between technical and anatomical success, and  hemodynamic and 
clinical success. Gary, 2003 has divided post treatment evaluation into three; anatomical success, 
hemodynamic success and clinical success (Gray et al., 2003).  For the purpose of this study and 
to avoid confusion, we use the term of technical success and hemodynamic success. 
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2.6.1  Technical (anatomical) success 
 Technical success post PTA treatment is defined as the achievement of residual diameter 
stenosis of 30% (Liang et al., 2014) (Aktas et al., 2015) or less (Tessitore et al., 2003) (Moist et 
al., 2003) (Tessitore et al., 2004). On the other hand, Valji, 1995 has defined technical success 
of PTA as a complete opening of the stenotic AVF with evidence of palpable thrills (Valji et al., 
1995). 
2.6.2  Hemodynamic success 
 Hemodynamic success is the restoration of hemodynamic parameters from its predefined 
values (Richard J. Gray, Amended 2014 ). Following PTA, there will be reduction of venous 
dialysis or static pressures (Richard J. Gray, Amended 2014 ), reduced arterial inflow pressure 
and maintained dialysis blood flow rate (Tang et al., 1998). On the other hand, Gary, 2003 
recommended the use of three parameters to determine PTA success which includes venous 
dynamic pressure, venous static pressure and access volume flows (Gray et al., 2003). In our 
setting, venous dialysis pressure (Vp) and blood pump flow rate (Qb) are two readings that 
readily available on hemodialysis machine during ongoing hemodialysis. They were routinely 
documented on patients’ record book. Neither static venous pressure (Vp0) nor blood flow 
access (Qa) was routinely recorded. Hence further explanation is more on Vp and Qb. 
a) Venous dialysis pressure (Vp)   
Post- PTA showed a drop in venous dialysis pressure significantly (Richard J. Gray, 
Amended 2014 ) (Schwab et al., 1989).A study by Beathard,1992, post PTA showed subsequent 
reduction of venous pressure on follow up; 36.5% at 1 week, 32.3% at 1 month and 22% at 
3month (Beathard, 1992). 
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b) Blood pump flow rate (Qb) 
To my best knowledge, not much study focused on the Qb changes in pre and post PTA 
study. A pilot study by Tessitore et al. (2003) all 32 patients who had PTA treatment showed a 
returned of Qb to the prescribed level with an increased  by 29.0 +- 35.2 ml/min within a week 
post PTA.  
 
2.6.3  Clinical success 
 Clinical success definition was taken into different perspective manner. Gary, 2003 
defined clinical success of PTA as the presence of uniform thrills and the resolution of pre-PTA 
clinical signs such as pain,  extremity edema, prolonged post dialysis bleeding and difficult 
access cannulation (Gray et al., 2003; Sprouse Ii et al., 2004). Whereas Valji et al., defined 
clinical success as the ability to resume successful dialysis within 24 hours of post treatment 
(Valji et al., 1995). Another different definition is the ability to provide adequate dialysis (Aktas 
et al., 2015) or the ability to perform at least one full dialysis treatment at 300 mL/min without 
recirculation (Liang et al., 2014) after PTA. 
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Chapter 3 
Objectives, Hypothesis 
3.1 General objective  
 To determine the association between percentages of stenosis with haemodialysis success 
in patients underwent PTA. 
 
3.2 Specific objectives 
1. To correlate percentage of stenosis with venous pressure (Vp) in pre and post- PTA. 
2. To correlate percentage of stenosis with blood pump flow rate (Qb) in pre and post- PTA. 
3. To compare mean percentage of stenosis in pre and post PTA. 
4. To compare mean of venous pressure (Vp) in pre and post PTA. 
5. To compare mean of blood pump flow rate (Qb) in pre and post PTA. 
 
3.3 Research hypothesis 
 There is high correlation between degree of stenosis and changes in haemodialysis 
parameters in pre- and post- Percutaneous Transluminal Angioplasty (PTA) of native Arterio-
Venous Fistula (AVF). 
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Chapter 4 
Methodology 
4.1  Study design 
 This cross sectional study was conducted in Advanced Minimally Invasive Endovascular 
and Neurointervention (AMIEN) unit in Hospital Universiti Sains Malaysia (HUSM) from June 
2014 till October 2015. This study received ethical approval from Human Research Ethics 
Committee of HUSM. Subjects obtained from cases referred to AMIEN unit. 
4.2  Population and Sample 
 4.2.1 Reference population 
  All End Stage Renal Disease (ESRD) patients on regular hemodialysis. 
 4.2.2 Source population 
  All ESRD patients who referred to AMIEN unit HUSM for dysfunctional   
  AVF and underwent PTA. 
 4.2.3 Inclusion criteria 
  1. All patients 18 years old and above. 
  2. All ESRD patients with dysfunctional upper limb AVF underwent PTA. 
  3.  The venous pressure (Vp) and blood pump flow rate (Qb) can be traced 
   from hemodialysis centre.  
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 4.2.4 Exclusion criteria 
  1. ESRD patient on Arterio-Venous Graft (AVG). 
  2. ESRD patient with central vein stenosis. 
  3. Technical and clinical failure post PTA. 
 4.2.5 Sampling method 
  Sampling method was by purposive method. 
 4.2.6 Sample size calculation 
  For objective 1 and 2: 
  Sample size calculation was made based on reference from website: 
www.cct.cuhk.edu.hk with power of study (1-β) of 80%, significance level(α) of 0.05 and 
expected correlation (r) ≈ 0.5. Sample size was calculated with reference based on Lachin 
(1981) Controlled Clinical Trials 2: 93-113. The corrected sample size was 35 subjects. 
 For objective 3, 4 and 5: 
  Sample Size Calculator version 1.7  from website: www.medic.usm.my/biostat  
was used to calculate the sample size using two means comparison with power of study 
(1-β) of 80%,  significance level (α) of 0.05, standard deviation of difference (σ) of 6.6 
(Ahya et al., 2001),  expected difference / effect size(Δ) of  3.9 and added drop out 20%. 
The corrected sample size was 57 subjects. 
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4.3 Research tools 
 4.3.1  Ultrasound 
 Preliminary ultrasound was usually performed before proceeded with fistulogram and 
PTA. This is done to locate the stenosis area and as a guidance for venous limb cannulation. We 
use the Ultrasound Colour and Power Doppler model ACUSON X300-SIEMENS, serial number 
340358 from German.  
 To perform this examination, patient is put on supine position with the upper limb of 
interest is in abducted position. Gel is then applied at the area of concerned. Linear probe of 
75MHz is used and the scanning performed to assess the patency of venous limb, anastomotic 
site (ostium) and arterial limb. Once area of puncture determined (Figure 4.1), the upper limb is 
cleaned and draped to make sure the sterility is maintained throughout procedure. Ultrasound 
probe is then cleaned and covered with sterile probe cover. Using 18G branula, venous limb 
cannulated under ultrasound guidance (Figure 4.2), either in longitudinal or axial plane in 
preference of the operator. The point of puncture is made towards the ostium, so that both ostium 
and venous limb can be assessed during fistulogram.  Stopper is applied and branula secured 
with tagaderm plaster. 
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Figure 4.2: Venous limb cannulation with branula within the vessel lumen. 
 
 
 
 
Figure 4.1: Preliminary ultrasound shows juxta-anastomosis site of stenosis (red arrow). 
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4.3.2  Fistulogram 
 Fistulogram is performed under Digital Subtraction Angiography (Moist et al.) guidance. 
We use Angiography Intraoperative Biplane AXIOM Artist Zee-SIEMENS, serial number 
154004 from German.  The purpose is to locate the site of stenosis (Figure 4.3) and to measure 
diameter of the affected vessel so that the appropriate selection of catheter and balloon can be 
made.  
 A 10 mls syringe filled with iodinated contrast (Visipaque 320mg/I) is connected to the 
branula through butterfly needle. Contrast was injected under fluoroscopy guidance and images 
were taken.  
 After fistulogram, central venogram of the ipsilateral site is proceeded. Sample with 
central venous stenosis is excluded. Assessment of central vein patency is important as it is 
closely related to AVF patency. Central vein represent the final common pathway for blood flow 
from the peripheral vessels to the heart. As the central vein stenosis progresses, back flow of 
blood to the AVF triggers further thrombosis formation and frequently end up with AVF 
dysfunction. 
 Once fistulogram done, the images were evaluated to locate the site of stenosis; ostium, 
venous limb or arterial limb (Figure 4.6). Measurement for diameter of stenosis and diameter of 
adjacent normal venous limb were then documented. If fistulogram finding is permissible, PTA 
will be proceeded. If the findings showed that it was not amenable for PTA in which there was a 
total occlusion, surgical revision were advised. 
 
 
 
